This content is from: European Union

Court of Justice rules in favour of Neurim and SPCs

The Court of Justice of the EU ruled this morning that supplementary protection certificates (SPCs) can be obtained for second medical use patents

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial